Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Clinical psychologist to receive Rockefeller University's 2012 Lewis Thomas Prize for Writing about Science

Clinical psychologist and author Kay Redfield Jamison will be presented with Rockefeller University's 2012 Lewis Thomas Prize for Writing about Science at a ceremony on June 5, 2013. The award recognizes Jamison's 1993 book Touched with Fire: Manic-Depressive Illness and the Artistic Temperament, which examines the relationship between artistic creativity and mood disorders.

8 May 2013

FDA: Migraine prevention medicines taken during pregnancy can impact children’s IQ

The U.S. Food and Drug Administration is alerting health care providers and patients that medications including and related to valproate sodium can cause decreased IQ scores in children whose mothers took the medication during pregnancy.

7 May 2013

Continuous circular cycling ‘a distinct bipolar disorder subtype’

Results from an Italian study suggest that there are distinct differences in clinical presentation, outcome, and treatment response between bipolar disorder patients with and without intervals between mood episodes.

30 Apr 2013

UCLA study shows individuals with BDD have global bad wiring in their brains

Body dysmorphic disorder is a disabling but often misunderstood psychiatric condition in which people perceive themselves to be disfigured and ugly, even though they look normal to others. New research at UCLA shows that these individuals have abnormalities in the underlying connections in their brains.

30 Apr 2013

New risk classification system proposed for prostate cancer

US researchers have put forward a risk stratification system for patients with intermediate-risk prostate cancer undergoing dose-escalated external-beam radiation therapy.

29 Apr 2013

Religiosity may influence depression, QoL in bipolar disorder

Results from a Brazilian study suggest that higher levels of intrinsic religiosity are associated with fewer depressive symptoms and increased quality of life in patients with bipolar disorder.

29 Apr 2013

New methods boost researchers' analytical powers by incorporating prior knowledge about SNPs function

As scientists probe and parse the genetic bases of what makes a human a human (or one human different from another), and vigorously push for greater use of whole genome sequencing, they find themselves increasingly threatened by the unthinkable: Too much data to make full sense of.

26 Apr 2013

Schizophrenia patients misinterpret anger

A study shows that patients with schizophrenia struggle to recognize angry facial expressions, often mistaking them for fear.

25 Apr 2013

Cardiovascular disease grave in patients with bipolar disorder

Cardiovascular disease has a particularly large impact on life expectancy if patients also have bipolar disorder, say researchers.

25 Apr 2013

Bipolar disorder questionnaires limited for patients with SUD

Researchers advise caution when using the Mood Disorder Questionnaire and the Hypomania Checklist-32 to diagnose bipolar disorder in patients treated for substance use disorders.

25 Apr 2013

New risk classification system proposed for prostate cancer

US researchers have put forward a risk stratification system for patients with intermediate-risk prostate cancer undergoing dose-escalated external-beam radiation therapy.

25 Apr 2013

Antipsychotics seemed to normalize gene expression pattern in people with bipolar disorder: Study

Every day, millions of people with bipolar disorder take medicines that help keep them from swinging into manic or depressed moods.

12 Apr 2013

Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

Omeros Corporation today announced positive data in the most commonly used model for studying the clinical and pathological features of multiple sclerosis (MS), further advancing its development program of GPR17-targeting compounds for the treatment of MS. Compounds previously discovered by Omeros that inhibit GPR17, an orphan G protein-coupled receptor (GPCR) unlocked by Omeros, significantly improved function from experimental autoimmune encephalomyelitis (EAE) in mice.

11 Apr 2013

REFRESH study: RP5063 shows promise for schizophrenia and schizoaffective disorder

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces top-line results from REFRESH, a phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.

10 Apr 2013

Research finds links between cannabis and mental illness

People with mental illnesses are more than seven times more likely to use cannabis weekly compared to people without a mental illness, according to researchers from the Centre for Addiction and Mental Health (CAMH) who studied U.S. data.

3 Apr 2013

Report shows identical genetic mutations are shared among neurodevelopmental disorders

A paper published this month in the prestigious medical journal The Lancet Neurology suggests that a broad spectrum of developmental and psychiatric disorders, ranging from autism and intellectual disability to schizophrenia, should be conceptualized as different manifestations of a common underlying denominator, "developmental brain dysfunction," rather than completely independent conditions with distinct causes.

3 Apr 2013

Study explores a better alternative for treating bipolar disorder

Toxicity problems and adverse side effects when taking lithium, the mainstay medication for treating bipolar disorder, are fostering a scientific hunt for insights into exactly how lithium works in the body - with an eye to developing a safer alternative.

28 Mar 2013

Mental illnesses such as schizophrenia, bipolar disorder or major depression no barrier to weight loss success

Through a program that teaches simple nutrition messages and involves both counseling and regular exercise classes, people with serious mental illness can make healthy behavioral changes and achieve significant weight loss, according to new Johns Hopkins research.

22 Mar 2013

APS to present scientific abstracts at Experimental Biology 2013

The American Physiological Society is one of six scientific societies sponsoring the meeting Experimental Biology 2013, being held April 20-24, 2013 at the Boston Convention and Exhibition Center, in Boston, Mass.

21 Mar 2013

Majority of women have postpartum depressive symptoms, finds study

A surprisingly high number of women have postpartum depressive symptoms, according to a new, large-scale study by a Northwestern Medicine- researcher.

15 Mar 2013